Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Neboglamine> ?p ?o }
Showing triples 1 to 69 of
69
with 100 triples per page.
- Neboglamine abstract "Neboglamine (INN) (formerly nebostinel; developmental code names CR-2249, XY-2401) is a positive allosteric modulator of the glycine site of the NMDA receptor which is under investigation for Rottapharm for the treatment of schizophrenia and cocaine dependence. It shows cognition- and memory-enhancing effects in animal models. As of June 2015, it is in phase II clinical trials for both schizophrenia and cocaine abuse.".
- Neboglamine atcPrefix "None".
- Neboglamine casNumber "163000-63-3".
- Neboglamine iupacName "(4S)-4-Amino-5-[(4,4-dimethylcyclohexyl)amino]-5-oxopentanoic acid".
- Neboglamine pubchem "3074827".
- Neboglamine thumbnail Neboglamine.svg?width=300.
- Neboglamine wikiPageExternalLink 800004810.
- Neboglamine wikiPageID "46941573".
- Neboglamine wikiPageLength "5768".
- Neboglamine wikiPageOutDegree "21".
- Neboglamine wikiPageRevisionID "699126767".
- Neboglamine wikiPageWikiLink Allosteric_modulator.
- Neboglamine wikiPageWikiLink Category:Amino_acids.
- Neboglamine wikiPageWikiLink Category:Antipsychotics.
- Neboglamine wikiPageWikiLink Category:NMDA_receptor_agonists.
- Neboglamine wikiPageWikiLink Category:Nootropics.
- Neboglamine wikiPageWikiLink Clinical_trial.
- Neboglamine wikiPageWikiLink Cocaine_dependence.
- Neboglamine wikiPageWikiLink Cognition.
- Neboglamine wikiPageWikiLink Cycloserine.
- Neboglamine wikiPageWikiLink Glycine.
- Neboglamine wikiPageWikiLink International_nonproprietary_name.
- Neboglamine wikiPageWikiLink Memory.
- Neboglamine wikiPageWikiLink Model_organism.
- Neboglamine wikiPageWikiLink NMDA_receptor.
- Neboglamine wikiPageWikiLink NRX-1074.
- Neboglamine wikiPageWikiLink Phases_of_clinical_research.
- Neboglamine wikiPageWikiLink Rapastinel.
- Neboglamine wikiPageWikiLink Rottapharm.
- Neboglamine wikiPageWikiLink Sarcosine.
- Neboglamine wikiPageWikiLink Schizophrenia.
- Neboglamine wikiPageWikiLinkText "Neboglamine".
- Neboglamine atcPrefix "None".
- Neboglamine c "13".
- Neboglamine casNumber "163000".
- Neboglamine chemspiderid "2333649".
- Neboglamine h "24".
- Neboglamine inchi "InChI=1S/C13H24N2O3/c1-137-5-915-12103-4-1117/h9-10H,3-8,14H2,1-2H3,/t10-/m0/s1".
- Neboglamine inchikey "VCRGLZYPNNAVRP-JTQLQIEISA-N".
- Neboglamine iupacName "-4".
- Neboglamine molecularWeight "256.34126".
- Neboglamine n "2".
- Neboglamine o "3".
- Neboglamine pubchem "3074827".
- Neboglamine smiles "CC1C".
- Neboglamine synonyms "Nebostinel; N--(L)-α-glutamine".
- Neboglamine wikiPageUsesTemplate Template:Drugbox.
- Neboglamine wikiPageUsesTemplate Template:Glutamatergics.
- Neboglamine wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- Neboglamine wikiPageUsesTemplate Template:Nootropics.
- Neboglamine wikiPageUsesTemplate Template:Reflist.
- Neboglamine subject Category:Amino_acids.
- Neboglamine subject Category:Antipsychotics.
- Neboglamine subject Category:NMDA_receptor_agonists.
- Neboglamine subject Category:Nootropics.
- Neboglamine hypernym Modulator.
- Neboglamine type ChemicalSubstance.
- Neboglamine type Drug.
- Neboglamine type ChemicalObject.
- Neboglamine type Thing.
- Neboglamine type Q8386.
- Neboglamine comment "Neboglamine (INN) (formerly nebostinel; developmental code names CR-2249, XY-2401) is a positive allosteric modulator of the glycine site of the NMDA receptor which is under investigation for Rottapharm for the treatment of schizophrenia and cocaine dependence. It shows cognition- and memory-enhancing effects in animal models. As of June 2015, it is in phase II clinical trials for both schizophrenia and cocaine abuse.".
- Neboglamine label "Neboglamine".
- Neboglamine sameAs Q20707894.
- Neboglamine sameAs m.013ddffj.
- Neboglamine sameAs Q20707894.
- Neboglamine wasDerivedFrom Neboglamine?oldid=699126767.
- Neboglamine depiction Neboglamine.svg.
- Neboglamine isPrimaryTopicOf Neboglamine.